|
US20050054682A1
(en)
*
|
1996-01-04 |
2005-03-10 |
Phillips Jeffrey O. |
Pharmaceutical compositions comprising substituted benzimidazoles and methods of using same
|
|
US6645988B2
(en)
*
|
1996-01-04 |
2003-11-11 |
Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
|
US6699885B2
(en)
*
|
1996-01-04 |
2004-03-02 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and methods of using same
|
|
US6489346B1
(en)
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
|
US5840737A
(en)
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
|
SE9600071D0
(sv)
|
1996-01-08 |
1996-01-08 |
Astra Ab |
New oral formulation of two active ingredients I
|
|
US8071128B2
(en)
|
1996-06-14 |
2011-12-06 |
Kyowa Hakko Kirin Co., Ltd. |
Intrabuccally rapidly disintegrating tablet and a production method of the tablets
|
|
AU5446798A
(en)
*
|
1996-11-27 |
1998-06-22 |
Procter & Gamble Company, The |
Compositions and methods for the treatment of gastrointestinal disorders
|
|
MX9703918A
(es)
*
|
1997-05-28 |
1998-11-30 |
J Marshall M D Barry |
Procedimiento para preparar un producto farmaceutico reactivo para deteccion de desorden gastrointestinal causado por bacteria en el tracto gastrointestinal superior.
|
|
SE510650C2
(sv)
*
|
1997-05-30 |
1999-06-14 |
Astra Ab |
Ny förening
|
|
WO1999010000A1
(en)
*
|
1997-08-25 |
1999-03-04 |
The Procter & Gamble Company |
Combined preparations for treating upper gastrointestinal tract distress
|
|
PL196163B1
(pl)
*
|
1997-12-08 |
2007-12-31 |
Altana Pharma Ag |
Nowa postać leku do podawania doustnego związków aktywnych nietrwałych w środowisku kwaśnym, zastosowanie jednostek związku aktywnego do wytwarzania leku do podawania doustnego oraz sposób wytwarzania nowej postaci leku do podawania doustnego
|
|
SE9704869D0
(sv)
*
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New pharmaceutical formulaton II
|
|
SE9704870D0
(sv)
*
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New pharmaceutical formulation I
|
|
FR2774906B1
(fr)
*
|
1998-02-13 |
2000-05-12 |
Rhodia Chimie Sa |
Systeme d'encapsulation a coeur organique et a ecorce minerale a base d'hydroxycarbonate d'aluminium et son procede de preparation
|
|
US6328994B1
(en)
|
1998-05-18 |
2001-12-11 |
Takeda Chemical Industries, Ltd. |
Orally disintegrable tablets
|
|
US7122207B2
(en)
|
1998-05-22 |
2006-10-17 |
Bristol-Myers Squibb Company |
High drug load acid labile pharmaceutical composition
|
|
UA69413C2
(uk)
*
|
1998-05-22 |
2004-09-15 |
Брістол-Майерс Сквібб Компані |
Фармацевтична композиція, яка містить серцевину та ентеросолюбільну оболонку, фармацевтична композиція у вигляді сфероїдальних гранул, спосіб одержання сфероїдальних гранул та спосіб одержання фармацевтичної композиції
|
|
TW585786B
(en)
|
1998-07-28 |
2004-05-01 |
Takeda Chemical Industries Ltd |
Lansoprazole-containing rapidly disintegrable solid pharmaceutical composition
|
|
SE9803772D0
(sv)
*
|
1998-11-05 |
1998-11-05 |
Astra Ab |
Pharmaceutical formulation
|
|
EP1244430A4
(en)
*
|
1999-03-29 |
2004-01-14 |
Wyeth Corp |
COATING SYSTEM
|
|
JP2003504338A
(ja)
*
|
1999-07-12 |
2003-02-04 |
スミスクライン・ビーチャム・コーポレイション |
胸やけの処置法
|
|
DE60036014T2
(de)
|
1999-10-20 |
2008-04-30 |
Eisai R&D Management Co., Ltd. |
Methode zur stabilisierung von benzimidazol-verbindungen
|
|
US20040191276A1
(en)
*
|
1999-11-30 |
2004-09-30 |
Cutispharma, Inc. |
Compositions and kits for compounding pharmaceuticals
|
|
US20020064555A1
(en)
*
|
2000-09-29 |
2002-05-30 |
Dan Cullen |
Proton pump inhibitor formulation
|
|
US20020192299A1
(en)
*
|
2000-12-28 |
2002-12-19 |
Rajneesh Taneja |
Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
|
|
SE0101379D0
(sv)
|
2001-04-18 |
2001-04-18 |
Diabact Ab |
Komposition som hämmar utsöndring av magsyra
|
|
US8206741B2
(en)
|
2001-06-01 |
2012-06-26 |
Pozen Inc. |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
|
AR034757A1
(es)
*
|
2001-07-16 |
2004-03-17 |
Astrazeneca Ab |
Formulacion farmaceutica que comprende un inhibidor de bomba de protones y antiacidos
|
|
AR036354A1
(es)
*
|
2001-08-31 |
2004-09-01 |
Takeda Chemical Industries Ltd |
Preparacion solida
|
|
HUP0401686A3
(en)
*
|
2001-09-28 |
2008-04-28 |
Mcneil Ppc Inc |
Dosage forms having an inner core and outer shell with different shapes
|
|
US9358214B2
(en)
*
|
2001-10-04 |
2016-06-07 |
Adare Pharmaceuticals, Inc. |
Timed, sustained release systems for propranolol
|
|
US6929926B2
(en)
|
2001-10-15 |
2005-08-16 |
Barry J. Marshall |
Composition for the detection of gastrointestinal disorders
|
|
US7008777B2
(en)
|
2001-10-15 |
2006-03-07 |
Barry J. Marshall |
System for the detection of urease and method for using same
|
|
MXPA04007169A
(es)
*
|
2002-01-25 |
2004-10-29 |
Santarus Inc |
Suministro transmucosal de inhibidores de bomba de protones.
|
|
KR100479637B1
(ko)
*
|
2002-02-01 |
2005-03-31 |
한국화학연구원 |
란소프라졸을 함유하는 경구제제 및 그의 제조방법
|
|
CO5400144A1
(es)
*
|
2002-03-11 |
2004-05-31 |
Novartis Ag |
Compuestos organicos
|
|
CN100553625C
(zh)
|
2002-04-09 |
2009-10-28 |
弗拉梅技术公司 |
活性成分微囊的口服混悬液
|
|
US20030228363A1
(en)
*
|
2002-06-07 |
2003-12-11 |
Patel Mahendra R. |
Stabilized pharmaceutical compositons containing benzimidazole compounds
|
|
US20040082618A1
(en)
*
|
2002-07-03 |
2004-04-29 |
Rajneesh Taneja |
Liquid dosage forms of acid labile drugs
|
|
US20040081700A1
(en)
*
|
2002-07-03 |
2004-04-29 |
Rajneesh Taneja |
Dose titratable liquid dosage forms of acid labile drugs
|
|
RU2211039C1
(ru)
*
|
2002-08-01 |
2003-08-27 |
Наркевич Владимир Эдуардович |
Антацидный препарат многослойного действия "полигель" для лечения язвенной болезни желудка и двенадцатиперстной кишки
|
|
US6663892B1
(en)
*
|
2002-08-19 |
2003-12-16 |
L. Perrigo Company |
Multiple portion tablet
|
|
SE0203065D0
(sv)
*
|
2002-10-16 |
2002-10-16 |
Diabact Ab |
Gastric acid secretion inhibiting composition
|
|
AU2003273000A1
(en)
|
2002-10-16 |
2004-05-04 |
Takeda Pharmaceutical Company Limited |
Stable solid preparations
|
|
MY148805A
(en)
|
2002-10-16 |
2013-05-31 |
Takeda Pharmaceutical |
Controlled release preparation
|
|
US9107804B2
(en)
*
|
2002-12-10 |
2015-08-18 |
Nortec Development Associates, Inc. |
Method of preparing biologically active formulations
|
|
US20070243251A1
(en)
*
|
2002-12-20 |
2007-10-18 |
Rajneesh Taneja |
Dosage Forms Containing A PPI, NSAID, and Buffer
|
|
US20040121004A1
(en)
*
|
2002-12-20 |
2004-06-24 |
Rajneesh Taneja |
Dosage forms containing a PPI, NSAID, and buffer
|
|
US8367111B2
(en)
*
|
2002-12-31 |
2013-02-05 |
Aptalis Pharmatech, Inc. |
Extended release dosage forms of propranolol hydrochloride
|
|
US20040166162A1
(en)
*
|
2003-01-24 |
2004-08-26 |
Robert Niecestro |
Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid
|
|
US7258981B2
(en)
*
|
2003-01-24 |
2007-08-21 |
Clontech Laboratories, Inc. |
Sensitive proteasome sensor constructs and methods for their design and use
|
|
CA2517005A1
(en)
*
|
2003-02-20 |
2004-09-02 |
Santarus, Inc. |
A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
|
|
EP1759692A3
(en)
*
|
2003-03-10 |
2007-09-12 |
Novartis AG |
Taste-masked solid veterinary compositions
|
|
WO2004082692A1
(ja)
*
|
2003-03-18 |
2004-09-30 |
Kowa Co., Ltd. |
制酸剤組成物
|
|
US8802139B2
(en)
|
2003-06-26 |
2014-08-12 |
Intellipharmaceutics Corp. |
Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
|
|
CA2531566C
(en)
*
|
2003-07-18 |
2013-05-07 |
Santarus, Inc. |
Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
|
|
WO2005007115A2
(en)
*
|
2003-07-18 |
2005-01-27 |
Santarus, Inc. |
Pharmaceutical composition for inhibiting acid secretion
|
|
US8993599B2
(en)
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
|
US20060165793A1
(en)
*
|
2003-08-04 |
2006-07-27 |
Koji Ukai |
Pharmaceutical preparation to be dispersed before administration
|
|
US7282050B2
(en)
*
|
2003-10-31 |
2007-10-16 |
Medtronic, Inc. |
Ablation of exterior of stomach to treat obesity
|
|
US7252665B2
(en)
*
|
2003-10-31 |
2007-08-07 |
Medtronic, Inc |
Ablation of stomach lining to reduce stomach acid secretion
|
|
US20070292498A1
(en)
*
|
2003-11-05 |
2007-12-20 |
Warren Hall |
Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
|
|
US7041124B2
(en)
*
|
2003-12-23 |
2006-05-09 |
Kimberly-Clark Worldwide, Inc. |
System and method for providing therapy to a portion of a body
|
|
GB0403165D0
(en)
*
|
2004-02-12 |
2004-03-17 |
Ct |
Novel uses for proton pump inhibitors
|
|
US8906940B2
(en)
*
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
|
US8815916B2
(en)
*
|
2004-05-25 |
2014-08-26 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
|
RU2288725C2
(ru)
*
|
2004-05-31 |
2006-12-10 |
Открытое Акционерное Общество "Нижегородский Химико-Фармацевтический Завод" (Оао "Нижфарм") |
Твердая лекарственная форма, проявляющая антацидное действие
|
|
EP1753405A4
(en)
*
|
2004-06-10 |
2008-09-17 |
Glatt Air Tech Inc |
SLOW RELEASE PHARMACEUTICAL PREPARATION
|
|
US20050281876A1
(en)
*
|
2004-06-18 |
2005-12-22 |
Shun-Por Li |
Solid dosage form for acid-labile active ingredient
|
|
US8394409B2
(en)
*
|
2004-07-01 |
2013-03-12 |
Intellipharmaceutics Corp. |
Controlled extended drug release technology
|
|
US10624858B2
(en)
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
|
GB2418854B
(en)
*
|
2004-08-31 |
2009-12-23 |
Euro Celtique Sa |
Multiparticulates
|
|
US8747895B2
(en)
*
|
2004-09-13 |
2014-06-10 |
Aptalis Pharmatech, Inc. |
Orally disintegrating tablets of atomoxetine
|
|
US9884014B2
(en)
*
|
2004-10-12 |
2018-02-06 |
Adare Pharmaceuticals, Inc. |
Taste-masked pharmaceutical compositions
|
|
EP1802285B1
(en)
*
|
2004-10-21 |
2013-02-27 |
Aptalis Pharmatech, Inc. |
Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
|
|
US20060105038A1
(en)
*
|
2004-11-12 |
2006-05-18 |
Eurand Pharmaceuticals Limited |
Taste-masked pharmaceutical compositions prepared by coacervation
|
|
US20060165797A1
(en)
*
|
2005-01-12 |
2006-07-27 |
Pozen Inc. |
Dosage form for treating gastrointestinal disorders
|
|
US8673352B2
(en)
|
2005-04-15 |
2014-03-18 |
Mcneil-Ppc, Inc. |
Modified release dosage form
|
|
US9161918B2
(en)
|
2005-05-02 |
2015-10-20 |
Adare Pharmaceuticals, Inc. |
Timed, pulsatile release systems
|
|
SE530605C2
(sv)
*
|
2005-09-29 |
2008-07-15 |
Barbara Nelson |
Läkemedel innehållande ett syrahämmande medel, avseende att användas för att motverka och bota luftvägssjukdomar
|
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
|
KR20080081071A
(ko)
*
|
2005-12-28 |
2008-09-05 |
다케다 야쿠힌 고교 가부시키가이샤 |
방출 제어 고형 제제
|
|
JP5457830B2
(ja)
*
|
2006-04-03 |
2014-04-02 |
オディディ，イサ |
オルガノゾル被膜を含む制御放出送達デバイス
|
|
WO2007122478A2
(en)
*
|
2006-04-20 |
2007-11-01 |
Themis Laboratories Private Limited |
Multiple unit compositions
|
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
|
JP2009538901A
(ja)
*
|
2006-06-01 |
2009-11-12 |
デクセル ファーマ テクノロジーズ エルティーディー． |
複式ユニット製薬的製剤
|
|
AR056062A1
(es)
*
|
2006-06-05 |
2007-09-19 |
Bago Sa Labor |
Composicion farmaceutica antiacida en forma de polvo, preparacion farmaceutica que la comprende y proceso para su preparacion
|
|
CN101120930B
(zh)
*
|
2006-08-11 |
2010-09-29 |
石药集团中奇制药技术（石家庄）有限公司 |
一种奥美拉唑组合物及其制备方法
|
|
US20090092658A1
(en)
*
|
2007-10-05 |
2009-04-09 |
Santarus, Inc. |
Novel formulations of proton pump inhibitors and methods of using these formulations
|
|
EP2086543A2
(en)
|
2006-10-27 |
2009-08-12 |
The Curators of the University of Missouri |
Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
|
|
US20080194307A1
(en)
*
|
2007-02-13 |
2008-08-14 |
Jeff Sanger |
Sports-based game of chance
|
|
CN101259140B
(zh)
*
|
2007-03-08 |
2012-08-22 |
重庆北碚现代应用药物研究所 |
一种治疗胃炎、胃溃疡及十二指肠溃疡的复方药物及其制备方法
|
|
AU2007352872B2
(en)
*
|
2007-05-07 |
2013-03-14 |
Evonik Operations Gmbh |
Solid dosage forms comprising an enteric coating with accelerated drug release
|
|
EP2044929A1
(en)
*
|
2007-10-04 |
2009-04-08 |
Laboratorios del Dr. Esteve S.A. |
Oral fast distintegrating tablets
|
|
ITFI20070253A1
(it)
*
|
2007-11-09 |
2009-05-10 |
Valpharma Internat S P A |
Formulazioni farmaceutiche per la somministrazione di ipp.
|
|
WO2009105568A1
(en)
|
2008-02-20 |
2009-08-27 |
The Curators Of The University Of Missouri |
Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same
|
|
EP2127643A1
(de)
*
|
2008-05-30 |
2009-12-02 |
Bayer Schering Pharma Aktiengesellschaft |
Orale Pelletformulierungen mit zeitversetzter Wirkstofffreigabe
|
|
WO2010029335A1
(en)
|
2008-09-09 |
2010-03-18 |
Astrazeneca Uk Limited |
Method for delivering a pharmaceutical composition to patient in need thereof
|
|
WO2010038241A2
(en)
*
|
2008-09-30 |
2010-04-08 |
Panacea Biotec Limited |
Pharmaceutical compositions comprising of proton pump inhibitor, prokinetic agent and alginic acid
|
|
JP2012072061A
(ja)
*
|
2009-01-29 |
2012-04-12 |
Eisai R & D Management Co Ltd |
新規組成物
|
|
WO2010151697A1
(en)
*
|
2009-06-25 |
2010-12-29 |
Pozen Inc. |
Method for treating a patient in need of aspirin therapy
|
|
JP2012531409A
(ja)
|
2009-06-25 |
2012-12-10 |
アストラゼネカ・アクチエボラーグ |
Ｎｓａｉｄ関連潰瘍を発症するリスクがある患者の処置方法
|
|
JP5309262B2
(ja)
|
2009-12-02 |
2013-10-09 |
アプタリス ファーマ リミテッド |
フェキソフェナジン・マイクロカプセル及びそれを含む組成物
|
|
WO2011080500A2
(en)
|
2009-12-29 |
2011-07-07 |
Orexo Ab |
New pharmaceutical dosage form for the treatment of gastric acid-related disorders
|
|
WO2011080501A2
(en)
|
2009-12-29 |
2011-07-07 |
Orexo Ab |
New pharmaceutical dosage form for the treatment of gastric acid-related disorders
|
|
WO2011080502A2
(en)
|
2009-12-29 |
2011-07-07 |
Orexo Ab |
New pharmaceutical dosage form for the treatment of gastric acid-related disorders
|
|
UY33173A
(cg-RX-API-DMAC7.html)
*
|
2010-01-08 |
2011-07-29 |
Eurand Inc |
|
|
AU2011242177B8
(en)
|
2010-04-23 |
2015-06-04 |
S-Biotek Holding Aps |
A solid pharmaceutical composition for neutralizing stomach acid
|
|
US9539214B2
(en)
|
2011-12-28 |
2017-01-10 |
Pozen Inc. |
Compositions and methods for delivery of omeprazole plus acetylsalicylic acid
|
|
US20140127296A1
(en)
*
|
2012-11-05 |
2014-05-08 |
Kenneth John Tibbs |
Pharmaceutical preparation and method for treatment of diabetes
|
|
US20150238514A1
(en)
*
|
2014-02-21 |
2015-08-27 |
William Armstrong |
Protective Supplement Configuration
|
|
US20170042806A1
(en)
|
2015-04-29 |
2017-02-16 |
Dexcel Pharma Technologies Ltd. |
Orally disintegrating compositions
|
|
WO2017185123A1
(en)
*
|
2016-04-29 |
2017-11-02 |
Alan Thompson |
Veterinary composition
|
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
|
TR201723199A2
(tr)
*
|
2017-12-30 |
2019-07-22 |
Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi |
Yeni farmasötik bileşimler.
|
|
KR102006777B1
(ko)
*
|
2018-01-29 |
2019-10-08 |
주식회사 종근당 |
에스오메프라졸 및 탄산수소나트륨을 포함하는 약제학적 제제
|
|
KR102080023B1
(ko)
|
2018-01-29 |
2020-02-21 |
주식회사 종근당 |
에스오메프라졸 및 탄산수소나트륨을 포함하는 안정한 약제학적 조성물
|
|
WO2020040438A1
(ko)
|
2018-08-23 |
2020-02-27 |
주식회사 종근당 |
에스오메프라졸 및 탄산수소나트륨을 포함하는 우수한 방출특성을 갖는 약제학적 제제
|
|
US20240100087A1
(en)
*
|
2019-10-17 |
2024-03-28 |
Hanmi Pharm. Co., Ltd. |
Pharmaceutical composition comprising proton pump inhibitor and antacid
|
|
BR112022014430A2
(pt)
*
|
2020-01-23 |
2022-09-13 |
Hanmi Pharm Ind Co Ltd |
Formulação farmacêutica composta
|
|
EP4070789A4
(en)
*
|
2020-01-23 |
2024-01-24 |
Hanmi Pharm. Co., Ltd. |
PHARMACEUTICAL COMPOSITE FORMULATION COMPRISING A PROTON PUMP INHIBITOR AND AN ANTIACID
|
|
KR102608889B1
(ko)
*
|
2020-07-14 |
2023-12-04 |
한미약품 주식회사 |
프로톤 펌프 저해제 및 제산제를 포함하는 약제학적 복합제제 및 그의 제조방법
|
|
KR20220065997A
(ko)
*
|
2020-11-13 |
2022-05-23 |
(주)휴온스 |
라베프라졸 및 제산제를 포함하는 약제학적 복합제제 및 이의 제조방법
|
|
CN114569579B
(zh)
|
2020-12-02 |
2023-10-31 |
丽珠医药集团股份有限公司 |
肠溶微丸、其制备方法和包含它的制剂
|
|
KR20230097346A
(ko)
*
|
2021-12-24 |
2023-07-03 |
한미약품 주식회사 |
프로톤 펌프 저해제 및 제산제를 포함하는 경구용 복합정제의 제조방법 및 이에 의해 제조된 경구용 복합정제
|
|
KR102553713B1
(ko)
*
|
2022-11-18 |
2023-07-10 |
고덕상 |
미네랄 촉매제를 이용한 양식어류사료 제조방법
|